Screening CTC rarely finds extracolonic findings among asymptomatic patients, but many are clinically significant.
Extracolonic findings detected during CT colonography (CTC) screening of asymptomatic patients are not common, but when found, they are often clinically significant, according to a study published in the American Journal of Roentgenology.
Researchers from the University of Wisconsin School of Medicine and Public Health in Madison sought to analyze the incidence and outcome of unsuspected significant extracolonic findings in the CT Colonography Reporting and Data System (C-RADS), classified as E4 findings, among patients who were undergoing CTC screening.
A total of 7,952 patients (3,675 men and 4,277 women), mean age of 56.7, participated in the study that took place between April 1, 2004 and June 30, 2012. All patients were undergoing screening for the first time. Potentially significant findings were retrospectively reviewed with additional analysis of follow-up of between two and 10 years and ultimate clinical outcome.
The results showed that 202 of the patients (2.5%) had a potentially significant (C-RADS category E4) extracolonic finding, but none had multiple E4 findings. Of these patients, 113 (56%) were recommended for further imaging and 89 (44%) for clinical follow-up. No patients had multiple category E4 findings. Of 180 patients (22 patients were lost to follow-up), 123 patients (68%) were found to have clinically significant disease; 42 (23%) and 57 patients (32%) with abdominal aortic or other visceral artery aneurysms requiring treatment or surveillance.
Most commonly involved organs and systems:
“Potentially significant extracolonic findings in asymptomatic adults at screening CTC are uncommon (2 to 3 percent of cases),” the researchers wrote. “However, most of these findings (68%) will prove to be clinically significant, including a number of malignancies and aneurysms requiring treatment or surveillance.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.